At the time, Todd didn’t need to use the PEG tube for nutrition because he was still eating by mouth, and almost seven years later, he’s still eating his meals by mouth. We did, however, begin using ...

Living near a moderate amount of green space may lower ALS risk. Very low greenness and very high greenness may increase risk, for different reasons. The study could have implications for public ...

The longer I live with ALS, the more I’m forced to learn about myself by constantly adjusting to my body’s limitations and learning how to pace my days. Lately, I’ve been taking lessons in how to ...

People who had a history of a traumatic head injury were nearly 50% more likely than those without head injury to have an ALS diagnosis, researchers found. However, multiple head ...

AC Immune’s experimental imaging agent ACI-19626 continues to show a good safety profile and has shown promise for detecting toxic TDP-43 protein clumps in people with amyotrophic lateral sclerosis ...

A study showed cholesterol-lowering statins do not significantly affect ALS progression or survival. Statin prescriptions for ALS patients should be based on metabolic needs, not ALS diagnosis. More ...

She was a woman of faith and told me her mantra was a quote from medieval mystic Julian of Norwich: “All shall be well, and all shall be well, and all manner of thing shall be well.” But things were ...

Outsee received an award to use AI for discovering new ALS treatments. The company's Nomaly platform will analyze genomic ...

Gauthier begins, “My father could use a little mercy now.” In that first verse, she sings that the fruits of his labor fall and rot slowly on the ground. “His work is almost over/ It won’t be long and ...

The APOE4 gene variant influences the spread of toxic TDP-43 protein clumps in ALS. APOE4 carriers are more likely to have ...

Neurizon received approval for a Phase 1 trial of liquid NUZ-001 for ALS in Australia. This liquid form addresses swallowing difficulties common in ALS patients. NUZ-001 aims to restore autophagy, ...

It is important to note that many of these technologies are still in early stages of development or clinical testing – they are not yet standard treatments, and what works for one person may not work ...